Literature DB >> 28720390

Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.

Susanna Ambrosio1, Carmen D Saccà1, Barbara Majello2.   

Abstract

The Lysine-specific demethylase 1, KDM1A/LSD1, plays a central role in the regulation of Pol II transcription through the removal of the activation mark (mono- and dimethyl lysine 4 of histone H3). LSD1 is often deregulated in human cancers, and it is frequently overexpressed in human solid cancers and leukemia. LSD1 regulates the epithelial mesenchymal transition (EMT) in epithelial cells, i.e., the ability to transition into mesenchymal cells, to lose homotypic adhesion and to acquire migratory capacity. From its initial discovery as a component of the Snail complex, multiple studies highlighted the causative role of LSD1 in cell invasiveness and EMT, describing its direct involvement in different molecular processes through the interaction with specific partners. Here we present an overview of the role of LSD1 in the EMT process, summarizing recent findings on its emerging functions in cell migration and invasion in cancer.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer; Cell migration and invasion; Chromatin; EMT; LSD1

Mesh:

Substances:

Year:  2017        PMID: 28720390     DOI: 10.1016/j.bbagrm.2017.07.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  12 in total

1.  Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy.

Authors:  Anne-Claire Guénantin; Imen Jebeniani; Julia Leschik; Erwan Watrin; Gisèle Bonne; Nicolas Vignier; Michel Pucéat
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

2.  Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Potential Treatment for Different Types of Cancers.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2017-10-27       Impact factor: 4.345

Review 3.  LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?

Authors:  Shaun Egolf; Brian C Capell
Journal:  Expert Opin Ther Targets       Date:  2020-05-07       Impact factor: 6.902

Review 4.  Ubiquitin Regulation: The Histone Modifying Enzyme's Story.

Authors:  Jianlin Wang; Zhaoping Qiu; Yadi Wu
Journal:  Cells       Date:  2018-08-27       Impact factor: 6.600

5.  Silencing Lysine-Specific Histone Demethylase 1 (LSD1) Causes Increased HP1-Positive Chromatin, Stimulation of DNA Repair Processes, and Dysregulation of Proliferation by Chk1 Phosphorylation in Human Endothelial Cells.

Authors:  Martyna Wojtala; Arkadiusz Dąbek; Dorota Rybaczek; Agnieszka Śliwińska; Ewa Świderska; Katarzyna Słapek; Assam El-Osta; Aneta Balcerczyk
Journal:  Cells       Date:  2019-10-07       Impact factor: 6.600

6.  Lysine-specific histone demethylase 1A (LSD1) in cervical cancer.

Authors:  Daniel Beilner; Christina Kuhn; Bernd P Kost; Julia Jückstock; Doris Mayr; Elisa Schmoeckel; Christian Dannecker; Sven Mahner; Udo Jeschke; Helene Hildegard Heidegger
Journal:  J Cancer Res Clin Oncol       Date:  2020-07-28       Impact factor: 4.553

7.  PHF8 Plays an Oncogene Function in Hepatocellular Carcinoma Formation.

Authors:  Hong Ye; Qing Yang; Shujie Qi; Hairong Li
Journal:  Oncol Res       Date:  2019-02-14       Impact factor: 5.574

Review 8.  The Role of H3K4 Trimethylation in CpG Islands Hypermethylation in Cancer.

Authors:  Giuseppe Zardo
Journal:  Biomolecules       Date:  2021-01-22

9.  Long intergenic non-protein-coding RNA 01446 facilitates the proliferation and metastasis of gastric cancer cells through interacting with the histone lysine-specific demethylase LSD1.

Authors:  Yifan Lian; Changsheng Yan; Yikai Lian; Renzhi Yang; Qiongyun Chen; Dan Ma; Weibin Lian; Jingjing Liu; Chengyan Luo; Jianlin Ren; Hongzhi Xu
Journal:  Cell Death Dis       Date:  2020-07-10       Impact factor: 8.469

Review 10.  LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target.

Authors:  Panagiotis Karakaidos; John Verigos; Angeliki Magklara
Journal:  Cancers (Basel)       Date:  2019-11-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.